NCT04875026 2022-09-19
Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial
Pierre Fabre Medicament
Phase 4 Completed
Pierre Fabre Medicament
Hoffmann-La Roche